Published in Antimicrob Agents Chemother on December 01, 1990
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. Antimicrob Agents Chemother (1994) 2.34
Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev (2008) 2.01
In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob Agents Chemother (1992) 1.64
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. Antimicrob Agents Chemother (1991) 1.54
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrob Agents Chemother (1996) 1.23
Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob Agents Chemother (1993) 1.23
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother (1991) 1.19
Beige mouse model for Mycobacterium avium complex disease. Antimicrob Agents Chemother (1995) 1.13
Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J Clin Microbiol (1995) 1.00
Activity of quinolones against mycobacteria. Drugs (1995) 0.94
Bacterial challenges and evolving antibacterial drug strategy. Postgrad Med J (1992) 0.85
Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. Antimicrob Agents Chemother (1996) 0.78
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob Agents Chemother (1989) 4.79
Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother (1982) 3.84
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob Agents Chemother (1986) 2.62
Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative. Antimicrob Agents Chemother (1988) 2.52
Pharmacokinetics of a novel quinolone, AT-4140, in animals. Antimicrob Agents Chemother (1990) 2.42
In vitro activity of PD 127,391, an enhanced-spectrum quinolone. Antimicrob Agents Chemother (1988) 2.09
Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother (1987) 1.73
Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. Antimicrob Agents Chemother (1987) 1.55
Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother (1988) 1.52
MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. Antimicrob Agents Chemother (1990) 1.18
Effects of surface-active agents on drug susceptibility levels and ultrastructure of Mycobacterium avium complex organisms isolated from AIDS patients. Diagn Microbiol Infect Dis (1988) 1.03
Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol (1995) 3.60
Predicting Mycobacterium avium complex bacteremia in patients infected with human immunodeficiency virus: a prospectively validated model. Clin Infect Dis (1994) 3.30
Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 3.17
The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 2.92
Myocardial changes associated with cardiogenic shock. N Engl J Med (1971) 2.67
Rapid confirmatory identification of Neisseria gonorrhoeae with lectins and chromogenic substrates. J Clin Microbiol (1984) 2.58
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med (1986) 2.53
Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med (1988) 2.33
Infection-control guidelines for patients with the acquired immunodeficiency syndrome (AIDS). N Engl J Med (1983) 2.26
Human infection with Edwardsiella tarda. Ann Intern Med (1969) 2.25
Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. J Clin Microbiol (1985) 2.21
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65). J Clin Microbiol (1989) 2.04
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother (1995) 2.01
Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation (1972) 1.94
High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis (1994) 1.93
Quantitative culture of Mycobacterium tuberculosis from clinical sputum specimens and dilution endpoint of its detection by the Amplicor PCR assay. J Clin Microbiol (1995) 1.89
Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol. J Clin Invest (1972) 1.74
Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother (1987) 1.73
Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71
Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.66
Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci. J Clin Microbiol (1985) 1.65
Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med (1995) 1.62
Successive bacteremias with "Campylobacter cinaedi" and "Campylobacter fennelliae" in a bisexual male. J Clin Microbiol (1987) 1.60
Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. Antimicrob Agents Chemother (1987) 1.55
Diagnosis and surgical treatment of mitral regurgitation secondary to ruptured chordae tendineae. N Engl J Med (1967) 1.54
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis (1994) 1.53
Autopsy findings with permanent pervenous pacemakers. Circulation (1969) 1.53
Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother (1988) 1.52
Bacterial characterization by flow cytometry. Science (1983) 1.52
Recurrence of group B streptococcal infection. J Pediatr (1976) 1.48
Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction. Circulation (1973) 1.40
Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol (1990) 1.39
Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency virus. Arch Intern Med (1992) 1.38
Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774. Am Rev Respir Dis (1989) 1.37
Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction. Circulation (1972) 1.35
The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis (1994) 1.34
Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med (1993) 1.32
In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrob Agents Chemother (1982) 1.30
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria. Antimicrob Agents Chemother (1981) 1.29
An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med (1982) 1.27
The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis (1990) 1.25
Sequential atrioventricular pacing in heart block complicating acute myocardial infarction. N Engl J Med (1970) 1.25
Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis (1999) 1.25
Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome. J Clin Microbiol (1989) 1.23
Human fecal flora under controlled diet intake. Am J Clin Nutr (1970) 1.23
Clinical trial comparing bacitracin with Strep-A-Chek for accuracy and turnaround time in the presumptive identification of Streptococcus pyogenes. J Clin Microbiol (1986) 1.23
Paravalvular leaks and hemolytic anemia following insertion of Starr-Edwards aortic and mitral valves. J Thorac Cardiovasc Surg (1968) 1.23
The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection. Arch Pathol Lab Med (1989) 1.20
Mechanical circulatory assistance. Current status and experience with combining circulatory assistance, emergency coronary angiography, and acute myocardial revascularization. Circulation (1972) 1.19
Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob Agents Chemother (1992) 1.17
Relationship between lactic acid concentration and bacterial spoilage in ground beef. Appl Environ Microbiol (1983) 1.16
The medical treatment of dissecting aortic aneurysms. N Engl J Med (1972) 1.16
Antibody to the retrovirus associated with the acquired immunodeficiency syndrome (AIDS). Presence in presumably healthy San Franciscans who died unexpectedly. Arch Intern Med (1986) 1.15
Penicillin-resistant Streptococcus constellatus as a cause of endocarditis. Am J Dis Child (1982) 1.15
Therapy of dissecting aneurysms. Arch Surg (1967) 1.14
Biochemical properties of CO2-dependent streptococci. J Clin Microbiol (1980) 1.14
Serotypes of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1986) 1.11
Study of human renal disease by immunofluorescent methods. Arch Pathol (1967) 1.10
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. Antimicrob Agents Chemother (1992) 1.09
Incomplete relaxation between beats after myocardial hypoxia and ischemia. J Clin Invest (1974) 1.09
Use of the transbronchial biopsy for diagnosis of opportunistic pulmonary infections in acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol (1984) 1.08
Permanent endocardial pacing in complete heart block. Assessment of the technique and the advantages in 20 patients. Ann Intern Med (1967) 1.07
Surgery for complications of acute myocardial infarction. Circulation (1972) 1.07
Traumatic myocardial infarction. Report of a case with normal coronary angiogram. Ann Intern Med (1967) 1.06
Effects of intra-aortic balloon counterpulsation on cardiac performance, oxygen consumption, and coronary blood flow in dogs. Circ Res (1970) 1.06
Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol (1983) 1.06
Effects of exopolysaccharide production by viridans streptococci on penicillin therapy of experimental endocarditis. J Infect Dis (1985) 1.05
In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test. Infect Immun (1973) 1.04
Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS (1998) 1.04
Mitral regurgitation in idiopathic hypertrophic subaortic stenosis. N Engl J Med (1966) 1.04
Cardiac hemodynamics immediately following mitral valve surgery. J Thorac Cardiovasc Surg (1966) 1.03
Recovery of Bordetella bronchiseptica from patients with AIDS. Clin Infect Dis (1992) 1.02
Penicillin tolerance in experimental streptococcal endocarditis. Lancet (1979) 1.01
Bordetella pertussis versus non-L. pneumophila Legionella spp.: a continuing diagnostic challenge. J Clin Microbiol (1992) 1.01
Effect of storage temperature and pH on the stability of antimicrobial agents in MIC trays. J Clin Microbiol (1986) 1.01
Cardiac hemodynamics immediately following aortic valve surgery. J Thorac Cardiovasc Surg (1966) 1.00
Connective tissue abnormalities in spontaneous rupture of chordae tendineae. Arch Pathol (1971) 1.00
Surgical therapy for early complications of myocardial infarction. Surgery (1971) 1.00
Role of renin in acute postural homeostasis. Circulation (1970) 0.99
Evaluation of PPLO, A7B, E, and NYC agar media for the isolation of Ureaplasma urealyticum and Mycoplasma species from the genital tract. J Clin Microbiol (1984) 0.98
Bacteriology of the marine environment: implications for clinical therapy. Ann Emerg Med (1987) 0.98